Search

You searched for "cancer"

1930 results found

Epidemiology of ocular cancer in Cali

4 December 2024 | Nishita Patel | EYE - Pathology, EYE - Oncology

The aim of this study was to describe the population trends of incidence and survival rates of ocular cancer in Cali, Columbia. Data was retrieved from the Registro Poblacion de Cancer de Cali (RPCC, i.e. Population Cancer Registry of Cali)...

Cancer associated retinopathy

7 December 2020 | Abdul Muhyemin Tarin | EYE - Vitreo-Retinal, EYE - General

Abdul Muhyemin Tarin reviews the presentation, pathophysiology and management of this paraneoplastic syndrome. Case presentation A 60-year-old hypermetropic female patient presented with several months’ history of painless blurred vision. Visual acuity (VA) was 6/24 and 6/9-1 in right and left...

Retinoblastoma – the challenges of a rare cancer and the role of international partnerships

4 October 2023 | Richard Bowman, Mattan Arazi, Aniruddh Heroor, Kahaki Kimani, M Ashwin Reddy, Ido Didi Fabian, Swathi Kaliki | EYE - Paediatrics, EYE - Strabismus

Introduction: the global challenge The global burden of retinoblastoma (Rb) is one in 15,000-18,000 live births, which equates to 8000 new cases worldwide each year. The global disparities in Rb outcome represent a paradigm of health inequality worldwide [1]. In...

A phase 3 randomised trial of nicotinamide for skin cancer chemoprevention

1 December 2015 | Jonathan CP Roos | EYE - Oculoplastic, EYE - Orbit

To B3, or not to B3? That was the question asked in this controlled trial in which the authors were able to show that oral nicotinamide (vitamin B3) is able to reduce further skin cancer development in high risk patients....

A novel integrated practice unit (IPU) approach to periocular skin cancer management

4 December 2023 | Susana Morley, Catriona Downie | EYE - Oculoplastic, EYE - Oncology

The COVID-19 pandemic was one of the biggest challenges to face NHS workers. However, history has repeatedly shown that times of difficulty can result in the development of significant social and technological advances. We describe our own experience of this...

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

5 April 2022 | Helena Fawdry, Andrew Coombes | EYE - Cornea, EYE - General

Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...

Study finds telemedicine improves care for children with eye cancer

28 January 2025 | Telemedicine, retinoblastoma, research, Paediatric, international

Orbis announces new research that finds telemedicine can improve care for children with retinoblastoma, a form of childhood cancer that can lead to blindness. The study, published in JCO Global Oncology, is the first to show that virtual mentor-mentee relationships...

Ocular Melanoma UK launches Ocular Melanoma October to shine a light on rare eye cancer

13 October 2025 | oncology, cancer, charity, October, OMUK

Ocular Melanoma UK (OMUK) the nation’s only charity dedicated exclusively to supporting those affected by ocular melanoma, today launched Ocular Melanoma October – a nationwide campaign highlighting the realities of living with this rare, life-threatening and often misunderstood cancer. Each...

1 (current)
2
3
4
5
6
»